Arcadia Biosciences, Inc. (NASDAQ:RKDA) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on August 10, 2026.
At publication ·
Arcadia Biosciences, Inc. (NASDAQ:RKDA) · proxy filed
At a glance
Arcadia Biosciences, Inc. (NASDAQ:RKDA) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on August 10, 2026.
The Basic Materials company's proxy statement provides information for shareholders ahead of the annual meeting, including board nominations, executive compensation, and proposals for shareholder vote.
Arcadia Biosciences, Inc.'s stock currently trades at $0.65 with a market capitalization of $5.1M.
SEC filings provide mandatory disclosures that give investors access to the same material information available to institutional investors. Reviewing Arcadia Biosciences, Inc.'s filings alongside price action and analyst commentary provides a more complete picture of the company's current situation.
All SEC filings for Arcadia Biosciences, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View RKDA Stock Page
Browse all filings on our RKDA SEC filings page.
Public companies like Arcadia Biosciences, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
NASDAQ · RKDA
Keep reading
